Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with type 2 diabetes and have been referred to a hormone specialist (endocrinologist) because their blood sugar levels have been difficult to control.
- People who are currently using insulin as part of their diabetes treatment.
Who may not be able to join:
- People who were referred to a specialist for a reason other than poor blood sugar control, such as having episodes of low blood sugar.
- People who have a different type of diabetes (not type 2), or where the type of diabetes has not been clearly confirmed.
- People who use a type of insulin taken at mealtimes to manage blood sugar spikes (known as rapid-acting bolus insulin).
- People whose diabetes is currently in a state of serious, sudden worsening.
- People who are currently taking steroid medications (corticosteroids).
- People who need significant help from others to carry out everyday tasks, or who have been assessed as having cognitive (thinking or memory) difficulties — specifically, those with a Barthel index score below 60 (confirm with trial site).
- People for whom there is a language barrier that would affect their ability to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34 938960025
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glycate hemoglobin
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.